ライフサイエンスコーパス: improved prognosis

1 ity of BSCB in diabetic SCI rats, leading to improved prognosis.

2 reas a high level of EGFR ligands confers an improved prognosis.

3 ithin TLSs in human PDAC that correlate with improved prognosis.

4 ensity after a breast cancer diagnosis to an improved prognosis.

5 ting IL-21 levels, was found associated with improved prognosis.

6 of targeted treatment are associated with an improved prognosis.

7 s whereas home ownership was associated with improved prognosis.

8 c inhibition of complement C5, which greatly improved prognosis.

9 ntally changed the therapeutic landscape and improved prognosis.

10 inoma, it is associated with a significantly improved prognosis.

11 alopathy is critical for early treatment and improved prognosis.

12 tiretroviral therapy (ART) has significantly improved prognosis.

13 sponse to neoadjuvant chemoradiation have an improved prognosis.

14 etween TGFBR3, GPC1, and SDC3 expression and improved prognosis.

15 ansient and not necessarily indicative of an improved prognosis.

16 ver-kidney transplantation offer promise for improved prognosis.

17 nt-related mortality have contributed to the improved prognosis.

18 do respond to treatment with a significantly improved prognosis.

19 py for EAC is infrequent but associated with improved prognosis.

20 t and recurrent setting, and have an overall improved prognosis.

21 the parenchyma, identifies patients with an improved prognosis.

22 patients would accept this care only for an improved prognosis.

23 from Study IV and discussed the findings on improved prognosis.

24 c cardiomyopathy and diabetes mellitus, with improved prognosis.

25 nti-GM2 antibodies have been associated with improved prognosis.

26 of sporadic colorectal carcinomas that have improved prognosis.

27 agnitude of the DCH response correlated with improved prognosis.

28 otherapy and female sex were associated with improved prognosis.

29 ith RER-positive tumors have a significantly improved prognosis.

30 that patients with RER-positive CRC have an improved prognosis.

31 e to identify promising interventions and an improved prognosis.

32 States citizens, since therapy now offers an improved prognosis.

33 elates with enhanced AT2 gene expression and improved prognosis.

34 s while TC gene signature is associated with improved prognosis across multiple cancer types.

35 rmethylated and mutated cases have similarly improved prognosis after adjuvant chemotherapy.

36 Milan criteria (MC) in 1996 has dramatically improved prognosis after liver transplantation (LT) in p

37 RD and the need for RRT, contributing to the improved prognosis after TMVr.

38 point for every complete 100 cells per mm3) improved prognosis; age of 50 years or older (2 points)

39 Although HPV-positive HNSCC has improved prognosis and better treatment responses compar

40 ue-specific protection mechanisms may ensure improved prognosis and disease management against fungal

41 iltration of solid tumors is associated with improved prognosis and favorable responses to immunother

42 Indeed, owing to its improved prognosis and greater prevalence in younger ind

43 atures driven by ARE activity correlate with improved prognosis and luminal phenotypes in PCa patient

44 e inhibitors (TKIs) has led to significantly improved prognosis and overall survival in CML patients

45 l aspect of treating many cancers and offers improved prognosis and prolonged survival in many cases;

46 2-positive breast cancer are associated with improved prognosis and response to therapy.

47 of chromosomes 1p and 19q is associated with improved prognosis and responsiveness to therapy in pati

48 ies and elastic moduli, opening the door for improved prognosis and the design of novel fatigue resis

49 scriptionally altered loci as biomarkers for improved prognosis and therapy.

50 and regulation will hopefully translate into improved prognosis and treatment for patients suffering

51 ing the release or effect of PNE may lead to improved prognosis and/or a reduction in morbidity.

52 llomavirus-associated tumors seem to have an improved prognosis, and may respond differently to treat

53 ral nifedipine challenge is predictive of an improved prognosis, and potential clinical efficacy in P

54 approaches that may hold hope for obtaining improved prognosis are presented.

55 ng induction chemotherapy, appear to have an improved prognosis as compared with reports using standa

56 wing myocardial infarction may be related to improved prognosis as it may facilitate access to cardia

57 NOTCH3, or CREBBP were also associated with improved prognosis, as were mutations affecting PTPRD, E

58 ave an increased prevalence of ESRD, but the improved prognosis associated with remission is so signi

59 HPF group was independently associated with improved prognosis at 5 years (P =.002) in regression mo

60 manner is crucial for better management and improved prognosis, but is currently unavailable.

61 lorectal carcinomas has been associated with improved prognosis, but its clinical significance in spo

62 hat BRCA2-related EOC was associated with an improved prognosis, but the effect of BRCA1 remains uncl

63 ated HNSCCs have a distinct risk profile and improved prognosis compared to cancers associated with t

64 cularly classify human kidneys and offers an improved prognosis compared to traditional histopatholog

65 stage, HPV-driven OPSCCs are associated with improved prognosis compared with HPV-negative disease.

66 RECENT FINDINGS: Improved prognosis compared with systemic chemotherapy a

67 ositive disease who received trastuzumab had improved prognosis compared with women with HER2/neu-neg

68 en TGFBR2 and EMT that may contribute to the improved prognosis consistently observed in colon cancer

69 normal acute myeloid leukemia and to confer improved prognosis, especially in patients without a con

70 d platelet activation was associated with an improved prognosis, even after adjusting for systemic in

71 lls at the tumor center were associated with improved prognosis for cancer-specific survival (HR = 0.

72 mmunity to tumor antigens is associated with improved prognosis for many cancers.

73 c therapies has led to durable remission and improved prognosis for many diseases that in the past ca

74 contain erlotinib for KRAS mut+ patients and improved prognosis for mesenchymal tumors, better biomar

75 This model will be helpful towards improved prognosis for patients that may likely suffer f

76 The improved prognosis for patients with HIV-associated lymp

77 correlates with both response to therapy and improved prognosis for patients with oligodendrogliomas.

78 et strategies that may ultimately lead to an improved prognosis for the cancer patient.(1)

79 ly increased risk of Hodgkin's lymphoma, and improved prognosis for those who develop HIV-associated

80 d a correlation between PIBF1 expression and improved prognosis in breast cancer patients with nodal

81 with studies showing that MI correlates with improved prognosis in colon and gastric cancers.

82 indings indicate that instability confers an improved prognosis in colorectal cancer and, despite the

83 r and that its expression is associated with improved prognosis in ER+ breast cancer.

84 ality, and regression of ECG LVH may predict improved prognosis in hypertensive patients.

85 In contrast, mucosal healing predicts improved prognosis in IBD and reduced risk of CAC.

86 with protection from all-cause cirrhosis and improved prognosis in nonalcoholic steatohepatitis.

87 se agents can facilitate early diagnosis and improved prognosis in patients with bladder cancer.

88 The overall survival highlights an improved prognosis in patients with RCC in the era of ta

89 merging evidence linking high Se status with improved prognosis in patients with T2D and lower risk o

90 that WNT pathway activation correlates with improved prognosis in proneural gliomas, particularly in

91 s granzyme has been recently associated with improved prognosis in solid tumors.

92 DDIR signature conferred improved prognosis in two thirds of patients with TNBC t

93 lacement therapy (HRT) is associated with an improved prognosis in women with advanced heart failure

94 nd whether these changes are associated with improved prognosis independent of blood pressure reducti

95 One enhancing factor related to improved prognosis is a decrease in regulatory T cells (

96 Improved prognosis is associated with spontaneous liver

97 e influence of airway transport phenotype on improved prognosis is not known.

98 f axillary lymph node-positive patients with improved prognosis may be identified using a lower (< 3

99 relevant biomarkers for early diagnosis and improved prognosis of alcoholism and identify future pha

100 become even more clinically relevant due to improved prognosis of cancer patients.

101 Imatinib therapy has significantly improved prognosis of chronic myeloid leukemia.

102 , and anti-HER2 therapies have significantly improved prognosis of patients with HER2+ breast cancer.

103 nsitory period of euphoria engendered by the improved prognosis of pneumococcal pneumonia resulting f

104 ciated with a significantly reduced risk and improved prognosis of psoriasis and psoriatic arthritis,

105 available, but does not necessarily imply an improved prognosis or quality of life.

106 sion of favorable alleles does not guarantee improved prognosis or viral control.

107 t patients with node-positive disease had an improved prognosis over the two decades studied.

108 therapy adequacy was not associated with an improved prognosis, particularly for ICU-hospital-acquir

109 nosis is a key to therapeutic adaptation and improved prognosis, particularly for infections such as

110 cer, with a favorable disease profile and an improved prognosis, particularly in women.

111 tion of PCP have decreased its frequency and improved prognosis, PCP continues to be seen in both HIV

112 sting severity scores, we find significantly improved prognosis performance; AI-severity can therefor

113 crol immediately after HAART initiation also improved prognosis (relative hazard = 0.34, 95% confiden

114 nt atrial fibrillation is associated with an improved prognosis remains to be established.

115 tive (HPV(-)) counterpart to account for the improved prognosis seen in the former.

116 ich inflammatory profiles (if any) relate to improved prognosis.Streptococcus pneumonia is a common h

117 Improved prognosis, such as that achieved with the survi

118 th RER-positive tumors were found to have an improved prognosis: the 5-year survival probability for

119 agnosis and appears to be associated with an improved prognosis; this finding suggests that surgery s

120 Improved prognosis was seen with increasing current alco

121 and well-defined tumors were associated with improved prognosis, whereas lateral compartment involvem

122 particular, solid-predominant tumors had an improved prognosis with adjuvant radiotherapy.

123 The association of improved prognosis with plasmacytic infiltrates has been

124 ventricle hearts have resulted in remarkably improved prognosis, with the expectation of continued im

125 ry lymph node-positive breast cancer with an improved prognosis would be clinically useful.